Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Journal of Magnetic Resonance Imaging : JMRI|March 24, 2018
Repeatability, reproducibility, and accuracy of quantitative mri of the breast in the community radiology settingAnna G Sorace, Chengyue Wu, Stephanie L Barnes, et al.
Journal of Medical Imaging (Bellingham, Wash.)|December 5, 2017
Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted magnetic resonance imaging for predicting the response of locally advanced breast cancer to neoadjuvant therapy: a meta-analysisJohn Virostko, Allison Hainline, Hakmook Kang, et al.
Molecular Cancer Therapeutics|July 2, 2020
Comparison of Panitumumab-IRDye800CW and 5-Aminolevulinic Acid to Provide Optical Contrast in a Model of Glioblastoma MultiformeTiara S Napier, Neha Udayakumar, Aditi H Jani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
Quantitative [<sup>89</sup>Zr]Zr-Trastuzumab PET and Diffusion- Weighted MRI for Characterization of Metastatic HER2-Positive Breast Cancer with PET/MRIAmeer Mansur, Jonathan E McConathy, Erica Stringer-Reasor, et al.
Nuclear Medicine and Biology|March 9, 2026
Spatial resolution and image quality of radionuclides for PET imagingSharon L Samuel, Solana Fernandez, Shelbie J Cingoranelli, et al.
Head & Neck|October 26, 2021
Hyperintensity of integrin-targeted fluorescence agent IntegriSense750 accurately predicts flap necrosis compared to Indocyanine greenMelanie D Hicks, Alyssa K Ovaitt, Jason C Fleming, et al.
Nature Protocols|September 23, 2021
Quantitative magnetic resonance imaging and tumor forecasting of breast cancer patients in the community settingAngela M Jarrett, Anum S Kazerouni, Chengyue Wu, et al.
Scientific Reports|February 15, 2024
Dual anti-HER2/EGFR inhibition synergistically increases therapeutic effects and alters tumor oxygenation in HNSCCPatrick N Song, Shannon E Lynch, Chloe T DeMellier, et al.
Neoplasia (New York, N.Y.)|November 16, 2020
Evaluating patient-specific neoadjuvant regimens for breast cancer via a mathematical model constrained by quantitative magnetic resonance imaging dataAngela M Jarrett, David A Hormuth, Chengyue Wu, et al.
Molecular Pharmaceutics|April 4, 2023
Evaluation of a CD206-Targeted Peptide for PET Imaging of Macrophages in Syngeneic Mouse Models of CancerCandace C Parker, Ahmad Bin Salam, Patrick N Song, et al.
Pageof 10